Balance Sheet for Novartis AG (NVS)

$ 84.18   -0.25 (-0.30%) Volume: 1.88m 4:00 PM EDT 26-Oct-2020
After Hours:  $ 84.16   -0.02 (-0.02%) Volume: 4.64k 7:59 PM EDT 26-Oct-2020
Statement: View:
Assets [+] in Millions of Dollars
12/2019 12/2018 12/2017 12/2016 12/2015
Cash and Equivalents 11,112 13,271 8,860 7,007 4,674
Restrictable Cash - - - - -
Marketable Securities 334 2,693 625 770 773
Accounts Receivable 8,301 8,727 8,600 8,202 8,180
Loans Receivable - - - - -
Other Receivables 1,165 1,360 1,480 1,034 1,463
Receivables 10,337 11,024 11,100 10,202 10,551
Inventories, Raw Materials 751 931 841 705 658
Inventories, Work in Progress 3,024 3,087 2,957 2,700 2,905
Inventories, Purchased Components - - - - -
Inventories, Finished Goods 2,207 2,938 3,069 2,850 2,663
Inventories, Other 5,982 6,956 6,867 6,255 6,226
Inventories, Adjustments & Allowances - - - - -
Inventories 5,982 6,956 6,867 6,255 6,226
Prepaid Expenses 898 812 756 697 621
Current Deferred Income Taxes - - - - -
Other Current Assets 2,680 - - 2,697 2,992
Total Current Assets 29,504 35,563 28,208 24,931 22,845
Land and Improvements 512 696 720 687 688
Buildings and Improvement 11,463 14,135 14,064 13,113 12,857
Machinery, Furniture and Equipment 13,674 17,155 16,858 14,816 15,093
Construction in Progress 1,350 2,042 2,368 2,680 2,810
Fixed Assets, Other 1,677 - - - -
Fixed Assets, Total 28,676 34,028 34,010 31,296 31,448
Gross Fixed Assets 28,676 34,028 34,010 31,296 31,448
Accumulated Depreciation (14,930) (18,332) (17,546) (15,655) (15,466)
Net Fixed Assets 13,746 15,696 16,464 15,641 15,982
Intangibles 28,787 38,719 29,997 31,340 34,217
Cost in Excess 26,524 35,294 31,750 30,980 31,174
Non-Current Deferred Income Taxes 7,909 8,699 8,229 10,034 8,957
Other Non-Current Assets 176 290 201 200 156
Total Non-Current Assets 88,866 110,000 104,871 105,193 108,711
Total Assets 118,370 145,563 133,079 130,124 131,556
Liabilities [+] in Millions of Dollars
12/2019 12/2018 12/2017 12/2016 12/2015
Accounts Payable (20,173) 6,229 6,066 5,595 6,685
Short Term Debt 7,092 9,620 5,201 5,789 5,574
Notes Payable - - - - -
Accrued Expenses 4,665 4,894 4,340 3,671 3,893
Accrued Liabilities 4,665 4,894 4,340 3,671 3,893
Deferred Revenues 114 236 305 287 385
Current Deferred Income Taxes 1,793 1,295 1,603 1,119 1,106
Other Current Liabilities 36,566 8,628 7,491 6,867 7,171
Total Current Liabilities 28,264 29,607 23,403 22,209 23,708
Long Term Debt 20,353 22,470 23,224 17,897 16,327
Deferred Income Tax 5,867 7,475 5,168 6,657 6,355
Other Non-Current Liabilities 6,632 7,319 7,057 8,470 8,044
Minority Interest 77 78 59 59 76
Capital Lease Obligations 1,703 - - - -
Preferred Securities of Subsidiary Trust - - - - -
Preferred Equity Outside Shareholders' Equity - - - - -
Total Non-Current Liabilities 34,632 37,342 35,508 33,083 30,802
Total Liabilities 62,896 66,949 58,911 55,292 54,510
Preferred Shareholder's Equity - - - - -
Common Shareholder's Equity 55,474 78,614 74,168 74,832 77,046
Common Par 936 944 969 - -
Additional Paid in Capital - - - 972 991
Cumulative Translation Adjustments - - - - -
Retained Earnings - - - - -
Treasury Stock 80 69 100 76 101
Other Equity Adjustments 54,618 77,739 73,299 73,936 76,156
Total Capitalization 75,827 101,084 97,392 92,729 93,373
Total Equity 55,474 78,614 74,168 74,832 77,046
Total Liabilities & Shareholder's Equity 118,370 145,563 133,079 130,124 131,556
Cash Flow 5,949 7,397 2,665 523 12,219
Working Capital 1,240 5,956 4,805 2,722 (863)
Free Cash Flow 11,368 11,624 10,327 8,596 8,392
Invested Capital 75,827 101,084 97,392 92,729 93,373
Shares Outstanding - Common Class Only 2,265 2,311 2,317 2,374 2,374
Preferred Shares Outstanding - - - - -
Total Ordinary Shares 2,265 2,311 2,317 2,374 2,374
Total Common Shares Outstanding 2,265 2,311 2,317 2,374 2,374
Treasury Shares 262 - 299 253 303
Basic Weighted Shares Outstanding 2,291 2,319 2,346 2,378 2,403
Diluted Weighted Shares Outstanding 2,319 2,344 2,371 2,400 2,438